Q3 2018

Filed Nov 14, 2018 · 10-Q · 45 days after period end · 0001654954-18-012755

Q3 2018 · 10-Q

Revenue

$0.00

— vs Q3 2017

Net Income

-$1.60M

N/M vs Q3 2017

EPS Diluted

-$0.33

N/M vs Q3 2017

Gross Profit$0—

Operating Income

Same quarter

Metric	Q3 2018	Q3 2017	Q3 2016	Q3 2015
Revenue	$0.00	$0.00	$0.00	$0.00
Net Income	-$1.60M	-$717.82K	-$359.81K	-$112.63K
EPS Diluted	-$0.33	-$0.02	-$0.01	-$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR